Episode
Episode 197 - Eduardo Bravo - CEO of Citryll
- Podcast
- The BioHub - by Avetix
- Published
- Jul 7, 2026
- Duration seconds
- 2012
- Processing state
not_requested- Canonical source
- https://podcasters.spotify.com/pod/show/max-brennan4/episodes/Episode-197---Eduardo-Bravo---CEO-of-Citryll-e3loqao
Actions
POST https://stenobird.com/v1/public/podcasts/the-biohub-by-avetix-7252289/episodes/episode-197-eduardo-bravo-ceo-of-citryll/transcription-requests
Idempotently request low-priority transcript generation for this episode.GET https://stenobird.com/podcast/the-biohub-by-avetix-7252289/episode-197-eduardo-bravo-ceo-of-citryll.md
Read the agent-friendly Markdown representation of this episode resource.
Summary
Today, I'm delighted to welcome Eduardo, CEO of Citryll Therapeutics. Eduardo has built his career at the intersection of science, innovation, and business, leading the development of transformative therapies designed to address serious autoimmune and inflammatory diseases. With extensive experience in the biotechnology industry, Eduardo has played a key role in guiding companies from scientific discovery through clinical development and strategic growth. As CEO of Citryll Therapeutics, he is leading a team focused on pioneering treatments that target novel mechanisms of disease, with the ambition of improving outcomes for patients who currently have limited therapeutic options. In today's conversation, we'll explore Eduardo's career journey, what inspired him to pursue leadership in biotech, the science behind Citryll's approach, and the opportunities and challenges involved in bringing breakthrough therapies from the lab to the clinic